🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid c...
Status
Active Not Recruiting
Location
City of Hope /ID# 154105
Start Date
2017-02-02
Trial ID
NCT02993523
Treatments Being Tested
The goal of this clinical study is to compare the study drugs, magrolimab +...
Status
Terminated
Location
University of Arkansas for Medical Sciences
Start Date
2022-07-07
Trial ID
NCT05079230
Treatments Being Tested
This was a Phase 3, multicenter, randomized, double blind, placebo-controll...
Status
Completed
Location
Rocky Mountain Regional VA Medical Center/Eastern Colorado Health Care System /ID# 156524
Start Date
2016-07-11
Trial ID
NCT02755597
Treatments Being Tested
This Phase 3 multinational, randomized, double-blind study is designed to c...
Status
Completed
Location
The University of Arizona Cancer Centre-North Campus
Start Date
2017-06-19
Trial ID
NCT03112174
Treatments Being Tested
This phase II MyeloMATCH treatment trial compares the effect of adding vene...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-17
Trial ID
NCT06954987
Treatments Being Tested
The primary objective of this study is to evaluate if venetoclax when co ad...
Status
Completed
Location
H. Lee Moffit Cancer Center /ID# 164273
Start Date
2017-05-23
Trial ID
NCT03069352
Treatments Being Tested
This is a multicenter, 2-cohort Phase 2 study assessing both minimal residu...
Status
Completed
Location
City of Hope /ID# 1142-0047
Start Date
2016-09-28
Trial ID
NCT02910583
Treatments Being Tested
Cancer is a condition where cells in a specific part of the body grow and r...
Status
Recruiting
Location
City of Hope National Medical Center /ID# 279568
Start Date
2026-06-30
Trial ID
NCT07581002
Treatments Being Tested
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-06-18
Trial ID
NCT05564390
Treatments Being Tested
A Randomized, Placebo-Controlled Phase III Study of Induction and Consolida...
Status
Recruiting
Location
Tirol Kliniken GmbH
Start Date
2022-09-13
Trial ID
NCT04628026
Treatments Being Tested